Kim M. Lawrence

Mayo Clinic

Papers

1

Total Citations

123

H-Index

1

About

Kim M. Lawrence is a distinguished cytogeneticist whose pioneering work has fundamentally advanced the understanding of renal tumor biology. Her research centers on the chromosomal and genetic underpinnings of kidney cancers, with a particular focus on renal oncocytomas and chromophobe cell renal carcinomas. In her landmark 1992 study, "Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma," Lawrence provided critical insights into the distinct cytogenetic profiles of these tumor types, establishing foundational knowledge that has shaped subsequent diagnostic and therapeutic approaches. This highly cited work, with 123 citations, remains a cornerstone in the field, demonstrating her lasting impact on cancer genetics. Through meticulous karyotyping and comparative analysis, she revealed recurrent chromosomal aberrations that differentiate benign from malignant renal neoplasms, offering a clearer path for clinical classification. Lawrence’s contributions have not only enriched the scientific community’s grasp of tumorigenesis but also empowered pathologists and oncologists with tools for more precise patient management. Her legacy endures as a testament to the power of cytogenetic exploration in unraveling cancer’s complexities.

Research Focus

Key Achievements

1
H-Index
1
Papers
123
Total Citations
123
Avg Citations/Paper
🏆 Most Cited Paper
Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma
123 citations · 1992
📈 Most Prolific Year: 1992 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago